SOURCE: CLX Investment Company, Inc.

March 29, 2006 10:14 ET

CLX Investment Company Announces Successful Appearance for Zonda, Inc. at U.S. Food Safety Trade Show

TEMECULA, CA -- (MARKET WIRE) -- March 29, 2006 -- CLX Investment Company (OTC BB: CLXN) today announced that portfolio investment Zonda, Inc. has completed its successful exhibit at the 2006 Food Safety Summit (, billed as the largest trade show on food safety and quality assurance in the United States.

Zonda's exhibit at the 2006 Food Safety Summit featured its MoniTek and MicroQuik products, which rapidly detect bacteria on surfaces and microorganisms from culture, allowing food service employees to become aware of contamination. Contacts were made with distributors and a variety of participants in the U.S. food service industry, the vast majority of which must test for surface contamination on a regular basis, as well as confirm the presence of specific bacteria from culture.

The show, which was held last week in Las Vegas, Nevada, included 2,200 qualified attendees including virtually all of the major U.S. food processors, food manufacturers, restaurant chains, and food retailers, according to conference organizers. Major food service companies such as Kraft, Tyson, ConAgra, Burger King, McDonald's, Olive Garden, McCormick, Pepsi, Coca-Cola, Tropicana, Popeye's, Wendy's, Kroger, Wal Mart, and Winn-Dixie were listed as attendees at the show.

"The Zonda exhibit garnered significant attention from a large number of show visitors, as well as most of the other exhibiting company representatives," stated Tammy D. Dunn, chief executive officer of CLX Investment Company, who attended the event. "Food safety is of extreme importance in this industry, since contamination that leads to consumer illness can cripple food service businesses, and Zonda is already fielding contacts from U.S. distributors and quality assurance personnel from major food companies who are interested in the MoniTek and MicroQuik products."

CLX will be adding several photographs of the Zonda's Food Safety Summit booth to its website in the next several days and will provide the link once the photographs are available to view.

To sign up to receive information by email directly from CLX Investment Company when new press releases, investor newsletters, SEC filings, or other information is disclosed, please visit

About Zonda, Inc.

Zonda Inc., in which CLX holds a 31% equity interest, is expanding the distribution of its product lines into broader markets around the world. The company's product line includes innovative, rapid, self-contained diagnostic devices for the detection of chlamydia, gonorrhea, yeast and Group A Strep, as well as testing products for the food safety and environmental sanitation markets. The Chlamydia test is currently being distributed in an expanding number of European countries and carries a CE mark for both professional point-of-care and over-the-counter use. The gonorrhea, yeast and Group A Strep tests carry CE marks for professional point-of-care use, and Zonda is seeking similar approvals for over-the-counter sales of these products. Each of the Zonda infectious disease tests are marketed as superior to their competition due to their comparable accuracy (compared directly to PCR or DNA testing), ease of use, compact design, long shelf life, rapid results, and cost effectiveness.

About the Company

CLX Investment Company ( holds a 31% equity interest in Zonda, Inc. (, a privately held company that specializes in test products that serve the medical diagnostic, bacterial food testing and environmental surfaces testing markets. Also in the CLX investment portfolio is a 49% interest in eStrategy Solutions, Inc. (, a Texas-based e-learning provider that has developed online training solutions for government entities and other professional organizations. CLX has invested, and holds a common stock position, in ActionView International, Inc. (, a publicly traded global manufacturer and marketer of "smart" scrolling advertising billboards.

CLX has elected to be regulated as a Business Development Company pursuant to Section 54 of the Investment Company Act of 1940, and is pursuing a business plan wherein the Company seeks to make investment in developing companies with the goal of providing return for its shareholders.

All statements included in this release, including statements regarding potential future plans and objectives of CLX Investments are forward-looking statements. Such statements are necessarily subject to risks and uncertainties, some of which are significant in scope and nature beyond CLX Investments' control. There can be no assurance that such statements will prove accurate. Actual results and future events could differ materially from those anticipated in such statements depending on many factors. Historical results are not necessarily indicative of future performance.

Contact Information

  • Contact:
    Gemini Financial Communications
    A. Beyer
    Email Contact